- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.07 | 1.89 |
NAV | ₹16.66 | ₹39.37 |
Fund Started | 14 Sep 2023 | 25 Jun 2018 |
Fund Size | ₹1704.87 Cr | ₹5507.52 Cr |
Exit Load | Exit load of 1%, if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.07
1.89
NAV
₹16.66
₹39.37
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹1704.87 Cr
₹5507.52 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 26.66% | 21.93% |
3 Year | - | 29.75% |
5 Year | - | 25.03% |
1 Year
26.66%
21.93%
3 Year
-
29.75%
5 Year
-
25.03%
Holding Analysis
Equity | 98.41% | 96.99% |
Cash | 1.59% | 3.01% |
Equity
98.41%
96.99%
Cash
1.59%
3.01%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.26% |
Divi's Laboratories Ltd. | 9.58% |
Cipla Ltd. | 7.58% |
Lupin Ltd. | 5.59% |
Max Healthcare Institute Ltd. | 4.82% |
Krishna Institute of Medical Sciences Ltd | 3.88% |
Torrent Pharmaceuticals Ltd. | 3.66% |
Aster DM Healthcare Ltd. | 3.62% |
Aurobindo Pharma Ltd. | 3.51% |
Glenmark Pharmaceuticals Ltd. | 3.50% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.66% |
Dr. Reddy's Laboratories Ltd. | 9.66% |
Divi's Laboratories Ltd. | 9.03% |
Cipla Ltd. | 7.85% |
Aurobindo Pharma Ltd. | 6.34% |
Alkem Laboratories Ltd. | 4.12% |
Zydus Lifesciences Ltd. | 4.01% |
Lupin Ltd. | 3.98% |
Gland Pharma Ltd. | 3.95% |
Syngene International Ltd. | 2.46% |
Fund Manager
Name | Dhruv Muchhal | Dharmesh Kakkad |
Start Date | 14 Sep 2023 | 23 Feb 2021 |
Name
Dhruv Muchhal
Dharmesh Kakkad
Start Date
14 Sep 2023
23 Feb 2021
About Fund
Description | The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 14 Sep 2023 | 25 Jun 2018 |
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018